Literature DB >> 26474655

Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes.

Swarupa Panda1, Jonas A Nilsson2, Nelson O Gekara3.   

Abstract

Pattern-recognition receptors (PRRs) including Toll-like receptors, RIG-I-like receptors, and cytoplasmic DNA receptors are essential for protection against pathogens but require tight control to avert inflammatory diseases. The mechanisms underlying this strict regulation are unclear. MYSM1 was previously described as a key component of epigenetic signaling machinery. We found that in response to microbial stimuli, MYSM1 accumulated in the cytoplasm where it interacted with and inactivated TRAF3 and TRAF6 complexes to terminate PRR pathways for pro-inflammatory and type I interferon responses. Consequently, Mysm1 deficiency in mice resulted in hyper-inflammation and enhanced viral clearance but also susceptibility to septic shock. We identified two motifs in MYSM1 that were essential for innate immune suppression: the SWIRM domain that interacted with TRAF3 and TRAF6 and the metalloproteinase domain that removed K63 polyubiquitins. This study identifies MYSM1 as a key negative regulator of the innate immune system that guards against an overzealous self-destructive immune response.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26474655     DOI: 10.1016/j.immuni.2015.09.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  34 in total

1.  Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Authors:  Claudia Lentucci; Anna C Belkina; Carly T Cederquist; Michelle Chan; Holly E Johnson; Sherry Prasad; Amanda Lopacinski; Barbara S Nikolajczyk; Stefano Monti; Jennifer Snyder-Cappione; Bogdan Tanasa; M Dafne Cardamone; Valentina Perissi
Journal:  J Biol Chem       Date:  2016-12-30       Impact factor: 5.157

2.  Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.

Authors:  Meisam Naeimi Kararoudi; Brian P Tullius; Nitin Chakravarti; Emily J Pomeroy; Branden S Moriarity; Kathie Beland; Aurelien B L Colamartino; Elie Haddad; Yaya Chu; Mitchell S Cairo; Dean A Lee
Journal:  Semin Hematol       Date:  2020-11-19       Impact factor: 3.851

3.  TRAF6-Mediated Inflammatory Cytokines Secretion in LPS-induced Colorectal Cancer Cells Is Regulated by miR-140.

Authors:  Guangwei Zhu; Chunlin Lin; Zhibin Cheng; Qin Wang; Robert M Hoffman; Shree Ram Singh; Yongjian Huang; Wei Zheng; Shugang Yang; Jianxin Ye
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

4.  Deubiquitinase Mysm1 regulates macrophage survival and polarization.

Authors:  Xin Zhao; Xiao-Hui Huang; Xiao-Hui Dong; Yu-Han Wang; Hui-Xin Yang; Yan Wang; Youdi He; Shuang Liu; Jin Zhou; Changyong Wang; Xiao-Xia Jiang
Journal:  Mol Biol Rep       Date:  2018-11-01       Impact factor: 2.316

5.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

6.  Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation.

Authors:  Ping Li; Yan-Mei Yang; Suzi Sanchez; Dian-Chao Cui; Rui-Jie Dang; Xiao-Yan Wang; Qiu-Xia Lin; Yan Wang; Changyong Wang; Da-Fu Chen; Si-Yi Chen; Xiao-Xia Jiang; Ning Wen
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

7.  Mysm1 is required for interferon regulatory factor expression in maintaining HSC quiescence and thymocyte development.

Authors:  X F Huang; V Nandakumar; G Tumurkhuu; T Wang; X Jiang; B Hong; L Jones; H Won; H Yoshii; K Ozato; A Masumi; S-Y Chen
Journal:  Cell Death Dis       Date:  2016-06-09       Impact factor: 8.469

Review 8.  Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

Authors:  Gloria Lopez-Castejon; Mariola J Edelmann
Journal:  Mediators Inflamm       Date:  2016-08-14       Impact factor: 4.711

9.  The Evolutionary Origins of Recurrent Pancreatic Cancer.

Authors:  Hitomi Sakamoto; Marc A Attiyeh; Jeffrey M Gerold; Alvin P Makohon-Moore; Akimasa Hayashi; Jungeui Hong; Rajya Kappagantula; Lance Zhang; Jerry P Melchor; Johannes G Reiter; Alexander Heyde; Craig M Bielski; Alexander V Penson; Mithat Gönen; Debyani Chakravarty; Eileen M O'Reilly; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nicholas D Socci; Barry S Taylor; Christine A Iacobuzio-Donahue
Journal:  Cancer Discov       Date:  2020-03-19       Impact factor: 38.272

10.  Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6.

Authors:  Eunha Kim; Jiyoon Beon; Seulgi Lee; Seung Ju Park; Hyoungjoon Ahn; Min Gyu Kim; Jeong Eun Park; Wooseob Kim; Jae-Min Yuk; Suk-Jo Kang; Seung-Hyo Lee; Eun-Kyeong Jo; Rho Hyun Seong; Seyun Kim
Journal:  Sci Adv       Date:  2017-04-21       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.